伊之密(300415.SZ):實際控制人及其一致行動人擬合計減持不超過3%股份
格隆匯11月26日丨伊之密(300415.SZ)公佈,副董事長、實際控制人之一梁敬華先生及公司董事、副總經理、實際控制人之一陳立堯先生的一致行動人彭惠萍女士計劃以集中競價及大宗交易的方式減持公司股份。其中,梁敬華先生計劃通過大宗交易減持不超過237萬股;彭惠萍女士計劃通過大宗交易減持不超過699萬股、通過集中競價減持不超過468萬股(若減持期間公司實施送股、資本公積金轉增股本、配股等除權事項以及可轉債轉股事項,則對該數量進行相應調整),預計合計減持股份不超過1,404萬股,不超過公司目前總股本468,562,084股的3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.